RS Research

RS Research

RS Research

Next generation nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
Founded
2015
Raised
$1.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€1,100,000
Seed fund - 2017
ACT Venture Partners
Team Size
2
Employees
Location
Headquarters
Webrazzi

Biyoteknoloji girişimi RS Research, 900 bin euro yatırım aldı

Webrazzi

ACT Venture Partners İstanbul Teknopark girişimi RS Research'e 1,1 milyon euro yatırım yaptı

€1,100,000 Seed fund
FinSMEs

RS Research Raises €1.1M in Venture Capital Funding